Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, September 20, 2023
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
Tue, September 19, 2023
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
Prakhar Agrawal Initiated (AKRO) at Buy and Held Target at $69 on, Sep 19th, 2023
Prakhar Agrawal of Cantor Fitzgerald, Initiated "Akero Therapeutics, Inc." (AKRO) at Buy and Held Target at $69 on, Sep 19th, 2023.
Prakhar has made no other calls on AKRO in the last 4 months.
There are 5 other peers that have a rating on AKRO. Out of the 5 peers that are also analyzing AKRO, 0 agree with Prakhar's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Prakhar
- Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Increased Target to $60 on, Wednesday, September 13th, 2023
- Eric Joseph of "JP Morgan" Maintained at Buy with Increased Target to $62 on, Tuesday, September 5th, 2023
- Eliana Merle of "UBS" Initiated at Strong Buy and Held Target at $83 on, Monday, August 28th, 2023
- Michael Ulz of "Morgan Stanley" Maintained at Buy with Increased Target to $70 on, Monday, June 12th, 2023
- Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $64 on, Wednesday, June 7th, 2023
